Curcumin–Pomegranate Polyphenol Blend for Immune Support and Bioavailability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Maintaining a physically active lifestyle leads to inflammation and soreness, and conventional pharmaceuticals for managing these issues have known side effects, while existing curcumin and pomegranate extracts face challenges in bioavailability and synergistic immune support.
Innovation Solution
A composition combining optimized curcumin extract (Longvida®) and pomegranate extract (Pomella®) is formulated to enhance immune response, gut health, and reduce stress, with a synergistic effect achieved through specific ratios and formulations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional pharmaceuticals (NSAIDs) are used to manage inflammation and soreness, then inflammation and soreness are reduced, but liver damage and other side effects occur
Solution Approach 1:
The patent changes the chemical parameters by using natural polyphenolic compounds (curcuminoids and punicalagins) instead of synthetic NSAIDs. These compounds work through different biochemical pathways (modulating cytokine production and oxidative stress) to reduce inflammation without the hepatotoxic effects of conventional pharmaceuticals.
Solution Approach 2:
The patent combines two different natural extracts (curcumin extract and pomegranate extract) into a composite formulation. This synergistic combination allows the compounds to work together through multiple mechanisms (COX-2 inhibition, NF-κB blocking, antioxidant activity) to achieve anti-inflammatory effects without the harmful side effects of single-agent pharmaceuticals.
2Reliability
If curcumin and pomegranate extracts are used separately, then some immune support is provided, but bioavailability is limited and synergistic immune support is not achieved
Solution Approach 1:
The patent merges curcumin extract and pomegranate extract into a single standardized composition with specific ratios (curcuminoids: 5-30%, punicalagins: 3-50%). This combination creates synergistic effects where the compounds enhance each other's bioavailability and immune-modulating properties, overcoming the limitations of individual extracts.
Solution Approach 2:
The patent optimizes the concentration parameters of active compounds within specific ranges to maximize bioavailability and synergistic effects. The standardized formulation ensures consistent delivery of curcuminoids and punicalagins at levels that have been shown to enhance immune response while maintaining safety.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination significantly improves immune health, reduces inflammation, and enhances recovery from exercise-induced infections and injuries, promoting balanced immune responses without side effects.
Implementation Method 1
Curcumin acts as an antioxidant and anti-inflammatory agent by enhancing activities of endogenous antioxidants (i.e. superoxide dismutase, catalase, glutathione peroxidase)
Implementation Method 2
blunting the action of cyclooxygenase-2 (COX-2), and blocking the activation of nuclear factor kappa beta (NF-κb)
Implementation Method 3
The delivery system Longvida®, formulating curcumin with SLCP (Solid Lipid Curcumin Particle) technology, improves the bioavailability of curcumin, delivering curcumin to blood and tissues and even allowing curcumin to cross the blood-brain-barrier
Implementation Method 4
Punicalagins and other components of pomegranate extracts may be metabolized in the gut to urolithins
Implementation Method 5
Pomegranate and methylsulfonylmethane (MSM) have been shown to reduce oxidative stress and improve markers of systemic inflammation
Data Source
AI summary
This invention is directed to compositions comprising curcumin extract and pomegranate extract, and methods of improving immune response with the compositions. The compositions may be administered as a prebiotic and/or a dietary supplement.